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Abstract
An origin of bidirectional DNA replication was mapped to the promoter of the FMR1 gene in human
chromosome Xq27.3, which has been linked to the fragile X syndrome. This origin is adjacent to a
CpG island and overlaps the site of expansion of the triplet repeat (CGG) at the fragile X instability
site, FRAXA. The promoter region of FMR2 in the FRAXE site (approximately 600 kb away, in
chromosome band Xq28) also includes an origin of replication, as previously described. FMR1
transcripts were detected in foreskin and male fetal lung fibroblasts, while FMR2 transcripts were
not. However, both FMR1 and FMR2 were found to replicate late in S phase (approximately six hours
into the S phase of normal human fibroblasts). The position of the origin of replication relative to
the CGG repeat, and perhaps the late replication of these genes, might be important factors in the
susceptibility to triplet repeat amplification at the FRAXA and FRAXE sites.
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INTRODUCTION
Fragile X syndrome is an X-linked disorder that manifests most typically in males. Disease
severity in symptomatic females seems to depend on the fraction of cells in which the X
chromosome carrying the mutated FRAXA site remains active (Abrams et al., 1994;Rousseau
et al., 1991). Pathophysiological conditions associated with the syndrome include mental
retardation, autism or autistic-like behaviors, delays in speech and language development,
postpubescent macroorchidism, long and prominent ears and jaws, high-pitched speech,
hyperactivity, poor eye contact, and stereotypic hand movements, such as hand flapping and
hand biting (Cummings and Zoghbi, 2000;Farzin et al., 2006;Garcia-Nonell et al., 2006;Hatton
et al., 2006;Hou et al., 2006). Fragile X syndrome is the most common genetic disorder
associated with mental retardation or autism in males, with an estimated prevalence of 1 in
4000 to 1 in 6000 males. Additional physiological conditions have been associated with or
related to FRAXA, including tremor ataxia syndrome (Ennis et al., 2006;Greco et al.,
2006;Iwahashi et al., 2006;Jacquemont et al., 2006) and premature ovarian failure (Fassnacht
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et al., 2006;Meskhi and Seif, 2006;Woad et al., 2006). As its name implies, FRAXA was
originally identified through its association with a folate-sensitive fragile site at Xq27.3 in a
fraction of affected patients. Sequence analysis of cosmids and cDNAs mapping to this fragile
site revealed a polymorphic (CGG)n repeat in the 5′ untranslated region of the FMR1 gene at
Xq27.3, which is known as the FRAXA site (Verkerk et al., 1991). Triplet repeat amplification
in excess of 200 copies (full mutation) leads to hypermethylation of the FMR1 promoter region
and gene silencing, hence a loss-of-function effect in affected males (Terracciano et al.,
2005). In the pre-mutation stage, amplifications ranging from approximately 60 to 200 repeats,
are associated with increased transcription of the mutant FMR1 gene (Tassone et al., 2000). It
appears, therefore, that the onset of disease is related to the length of the trinucleotide repeat.
Interestingly, an intermediate length of the repeat (i.e., pre-mutation) makes the carrier
susceptible to further expansion of the repeat region.
The cause of expansion of triplet repeats is not known, but this expansion is likely to occur
during DNA replication in proliferating cells (Cleary and Pearson, 2005). Because of the
antiparallel structure of double-stranded DNA and because DNA polymerases can only add
nucleotides at the 3′ end of the growing strand, the two daughter strands are replicated by
different mechanisms during semiconservative DNA replication. The leading strand is
elongated in the same direction of the movement of the replication fork from an origin to a
termination site; the lagging strand must be synthesized discontinuously, with new fragments
initiated at Okazaki fragment Initiation Zones (OIZ) located approximately 150 - 300 nt apart
(Cleary and Pearson, 2005;Pearson et al., 2005). CGG and CTG triplet repeats have been shown
in vitro to slow or even stop DNA polymerases because of the formation of stable hairpins on
template DNA (McMurray, 1999) and it has been reported that the extent of inhibition of fork
progression due to this effect increases with the length of the repeat (Kang et al., 1995). The
expansion of triplet repeats has been thought to be closely linked to the ability of these
sequences to form alternative DNA structures, a degree of flexibility higher than non-repetitive
DNA, and the difficulty that DNA polymerases encounter in progressing through repetitive
DNA regions (Chastain et al., 1995;Chastain and Sinden, 1998;Pearson et al., 1998;Pearson
and Sinden, 1996;Pearson and Sinden, 1998;Pearson et al., 1998;Sinden, 1999). If the newly
synthesized DNA strand in these repeat regions forms unusual structures (such as hairpins),
mispriming followed by elongation may lead to the expansion of the repeat tract. It has been
reported that the CGG repeats on lagging strand DNA are more likely to form stable secondary
structures (e.g. hairpins) that may facilitate amplification (Siyanova and Mirkin, 2001).
Therefore, the location of the origin of replication with respect to the triplet repeat may
determine the probability that expansion during DNA replication will occur in one of the
daughter cells.
We reported previously the presence of an origin of replication in the transcriptional promoter
of the FMR2 gene (FRAXE), also implicated in fragile X syndrome, located on chromosome
Xq28, approximately 600 kb telomere-wise from the FRAXA site (Chastain et al., 2006). In
this report, we present the identification of the origin of bidirectional replication associated
with the FMR1 gene, the determination of its time of replication, and the expression status of
both FMR1 and FMR2 genes in normal human male skin and lung fibroblasts.
METHODS
Cell cultures
The human cells used in these studies were NHF1-hTERT, a cell line derived from normal
neonatal foreskin fibroblasts (Boyer et al., 1991) and immortalized by ectopic expression of
the catalytic subunit of telomerase (Heffernan et al., 2002); GM1604-hTERT, a male fetal lung
fibroblast cell line also immortalized by telomerase expression (Ouellette et al., 2000); and
CRL-1502 cells (ATCC), a strain of female fetal lung fibroblasts. The hTERT-immortalized
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cell lines were grown in minimal essential medium (Invitrogen, Carlsbad, CA) containing 2X
the concentration of MEM non-essential amino acids (Invitrogen). The CRL-1502 cells were
cultured according to ATCC recommended conditions. Growth media were further
supplemented with 2 mM L-glutamine (Invitrogen) and 10% fetal bovine serum (Sigma
Chemical Co., St. Louis, MO).
Cell synchronization and determination of replication timing
The protocol used to synchronize cultured human fibroblasts was described previously
(Cordeiro-Stone et al., 1986). Cells arrested at confluence were replated at lower densities in
medium containing 2 μg/ml of the DNA polymerase inhibitor aphidicolin, and incubated for
24 h (Brylawski et al., 2000;Tribioli et al., 1987). Once cells were released from the aphidicolin
inhibition, they resumed DNA synthesis at a normal rate and transited through the S phase as
a parasynchronous cohort. DNA synthesized in different 1-h windows of the S phase was
isolated by CsCl gradient centrifugation (Cordeiro-Stone et al., 1990). Samples containing
equal amounts of DNA were used for testing the timing of replication of the FMR1 region by
PCR, as described previously for the region of human chromosome X containing the FMR2
gene (Chastain et al., 2006). DNA samples from two synchronization experiments were tested
twice, each time using duplicate PCR reactions. PCR reactions were conducted under non-
saturating conditions as determined by a standard curve generated with genomic DNA sheared
to the same size as the test DNA (Cohen et al., 2002). Only when the correlation coefficient
for the standard curve was equal to or greater than 0.9 were the PCR results taken into
consideration.
Preparation of nascent DNA and mapping of the replication origin
Single-stranded nascent DNA ranging in size from ∼400-1000 nt in length was prepared from
logarithmically growing cells as described previously (Cohen et al., 2002). Quantitative PCR
was used to determine the relative copy number of selected genetic markers (Table I) from the
FMR1 gene region. A standard curve using sonicated genomic DNA (∼ 1500 bp) was amplified
together with the nascent DNA sample for each primer set, so that differences in amplification
efficiency would not affect the determination of relative abundance. Each preparation of short
nascent DNA was also tested by measuring the relative abundance of sequences at the lamin
B2 origin using previously described L5 (Cohen et al., 2002) and B13 (Giacca et al., 1994)
primers.
PCR
Primer3 (frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and the Prime program in the
Wisconsin Package (Genetics Computer Group, Madison, WI, version 8) were used to design
PCR primers for the amplification of DNA sequences within a length of DNA from nt
146697178 to nt 146701532 of chromosome band Xq27.3 as reported in Build 35 of human
genomic sequences available at the UCSC Genome Bioinformatics site
(www.genome.ucsc.edu). The primers are listed in Table 1 with their location, the size of the
PCR product, and the annealing temperature used in the PCR reaction. PCR was performed in
OmnE and PCR-Express thermocyclers (Thermo Electron Corp., Milford, MA) using Thermo-
Start Taq DNA polymerase (ABgene, Rochester, NY). PCR reaction conditions were: 95°C
for 15 min (once, for the activation of the polymerase), followed by 30-38 cycles of 94°C for
30 sec, annealing temperature (Table 1) for 30 sec, and elongation at 72°C for 30 sec. Some
primer sets (marked with asterisks in Table 1) required a two-step PCR program: 95°C for 15
min, 30 cycles of 94°C for 1 min and annealing/elongation temperature (Table 1) for 2 min.
For a few primer sets (as indicated in Table 1), 2% DMSO was also added to the reaction
mixture. PCR products were separated by gel electrophoresis on 2% agarose and stained with
ethidium bromide. Gel images were recorded with a digital imaging system (AlphaInnotech,
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San Leandro, CA) and the intensity of the bands was analyzed with AlphaEase software from
the same manufacturer. Microsoft Excel was used to graph the standard curves, determine the
equations of the linear regression lines, and calculate the genomic ng-equivalent value of the
unknown samples.
Reverse transcription PCR (RT-PCR)
Total RNA was isolated from NHF1-hTERT, 1604-hTERT, and CRL-1502 cells using the SV
Total RNA Isolation System (Promega, Madison, WI). RNA was quantified and aliquots were
run on agarose gels to check for quality. First strand cDNA synthesis was performed on 200
ng of total RNA using Superscript III (Invitrogen, Carlsbad, CA) and a reverse primer for either
FMR1 or FMR2. PCR was performed with one tenth of the cDNA reaction using Thermo-Start
DNA polymerase (ABgene, Rochester, NY) in an OmnE or Express thermocycler (Thermo
Electron Corp., Milford, MA). PCR was carried out according to the 3-step protocol described
above, with 35 cycles used for each primer set. Primer sequences were as follows: FMR1
forward gctgaagagaagatggaggag, reverse acaggaggtgggaatctgac; FMR2 forward
atgggagcggaggaatcaag, reverse ttctggactcggttggcaag. The PCR product for FMR1 extends
from exon 2 to 4 and the primer set for FMR2 extends from exon 2 to 3.
RESULTS
Mapping of an origin of DNA replication by measuring nascent strand abundance is based on
the concept that newly synthesized strands of DNA are elongated bidirectionally away from a
replication start. Therefore, within the population of nascent strands of different lengths
purified from the bulk of genomic DNA, the sequences closest to the origin will be found at
the highest relative abundance (Giacca et al., 1997), while sequences further from the origin
will be progressively less abundant. Semi-quantitative PCR with primer sets targeting the
region of interest (Cohen et al., 2002) is used to determine the relative abundance of specific
sequence markers in a preparation of nascent DNA fragments and thus establish which are the
closest to a functional origin of replication. This type of analysis on the sequence around the
promoter region of the FMR1 gene revealed a peak of abundance overlapping the triple repeat
sequence previously reported to be linked to the onset of fragile X syndrome. Both cell lines
studied displayed the peak of abundance with PCR marker E (Fig. 1 and 2). No other initiation
zone was detected in the 5 kb of surrounding sequence.
In both the FMR1 (this report) and FMR2 (Chastain et al., 2006) regions the origin of replication
was mapped within the transcriptional promoter. We analyzed the transcriptional activity of
FMR1 and FMR2 in the cell lines that were tested for origin activity (NHF1- and 1604-hTERT
cells; Fig. 3). FMR1 was expressed in both of these cell lines, but there was no detectable
expression of FMR2. These results indicate that even though the origins of replication
associated with both the FMR1 and FMR2 genes are located at their transcriptional promoter,
transcription itself is not necessary for origin firing. This is in agreement with previous reports
that showed that origins of replication associated with the human HPRT and G6PD
transcriptional promoters fire on both the active and inactive X chromosomes (Cohen et al.,
2003).
We determined that the FRAXA region corresponding to the FMR1 gene in chromosome
Xq27.3 replicates in the second half of the S phase in two normal human fibroblasts cell lines
(Fig. 4). We were interested in establishing precisely the timing of replication of the FMR1
gene, previously reported to be late replicating (Hansen et al., 1997;Hansen et al., 1993) by
using the same cells and the same method we applied previously to the FMR2 region (Chastain
et al., 2006). For a particular type of cell, genomic DNA is replicated according to a highly
organized and reproducible temporal order. A correlation has been proposed between the time
of replication and the expression of genes in metazoan cells, with expressed genes replicating
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early and silent genes replicated later in S phase (Hatton et al., 1988;Schwaiger and Schubeler,
2006). This difference in replication timing has been attributed to the chromatin status in the
genome: chromatin that is more gene-rich (euchromatin) is more open because of transcription
and replicates early, while gene-poor, more compacted chromatin (heterochromatin) replicates
later in S phase. In the region of the X chromosome we analyzed in these studies, however, we
found two genes, one transcriptionally active (FMR1) and the other inactive (FMR2), both
replicating towards the end of the S phase. Because of this atypical replication status, it is likely
that the FMR1 region displays an unusual chromatin structure, having both the epigenetic
markings for active transcription and, perhaps, some yet to be determined cis-acting element
determining the late replication timing (Hansen et al., 1997). A shift to replication even later
in S phase (closer to the S/G2 border), associated with the silencing of the gene, is found in
fragile X syndrome (Hansen et al., 1997). Based on published studies on X inactivation, we
would predict that this shift to later replication would occur during embryonic development
and should precede methylation of the promoter (reviewed in Heard, 2004). Therefore, it is
possible that triplet repeat expansion leading to the alteration of a cis-acting element that
controls replication timing may be involved in the switching of this gene to the inactive status
(i.e., DNA hypermethylated at the promoter) that is found in fragile X syndrome.
DISCUSSION
This study disclosed the presence of an active origin of replication in the promoter region of
the human FMR1 gene. Although the nascent DNA abundance method for origin mapping
allows the positioning of an origin in a fairly precise location, it does not specify an initiation
site at the nucleotide level. Because of the difficulty in amplifying certain sequences
(particularly CGG repeats), when analyzing the FMR1 origin region we could not generate
PCR products between or overlapping markers D and E, and E and F (Fig. 1). Therefore, we
cannot be certain that sequence markers in these areas are not represented at a relative
abundance higher than E. Consequently, we defined an “initiation region” as spanning from
the midpoint of the sequence between markers D and E to the midpoint of the sequence between
marker E and F (Fig. 1). Accordingly, the initiation region for the FMR1 origin spans 483 bp,
and it overlaps the triplet repeat site (Fig. 5A). Since no other initiation zone was detected
within the surrounding 5 kb, we assume that this is the origin responsible for the replication
of the triplet repeat tract. With the origin of replication in this position, the repeat (CGG)n is
located in the upper strand of the diagram (Fig. 5A), which would represent the template for
the lagging strand. This arrangement is not considered to be conducive to amplification
(Siyanova and Mirkin, 2001) because the strand containing the (GCC)n repeat would serve as
the template to the leading strand, which is synthesized continuously and is less likely to form
hairpin loops at the complementary (CGG)n repeat. In our study, however, the FMR1 origin
was mapped in neonatal (NHF1) and 12-week fetal cells (GM1604). In embryonic cells, where
more origins of DNA replication are likely to be active, replication through this repeat may be
controlled by another origin, not active in the adult cells, located on the 3′ side of the triplet
repeat (Fig 5B). In that case, the (GCC)n template would direct the synthesis of the lagging
strand, favoring the formation of secondary structures (e.g. CGG hairpins) in the nascent
complementary strand, possibly leading to expansion. This event would explain expansion
occurring in early development rather than in adult cells, as has been reported (Wohrle et al.,
1993). Further, if either origin selection or amplification is a stochastic rather than deterministic
process and expansion shows strong strand bias, then triplet repeat expansion mutations would
not be found in all adult cells of fragile X syndrome patients, which is consistent with diagnoses
of mosaicism for the triplet repeat expansion seen in affected patient. In fact, it has been
reported that fragile X female fetal fibroblasts display dynamic instability in culture, whereas
fragile X adult male fibroblasts do not (Sun and Han, 2004). Another explanation for the
generation of instability in the FMR1 region would be the presence of acquired changes in the
location where Okazaki fragments are primed relative to the position of the repeat (Cleary and
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Pearson, 2005). It has been reported that difficulty in the anchoring of primers in repeat regions
(Lyons-Darden and Topal, 1999) may favor slippage in primer binding and lead to expansion.
Interestingly, in the origin of replication associated with the promoter/trinucleotide repeat of
the FMR2 gene that we reported recently (Chastain et al., 2006), the conditions are reversed.
The initiation region (defined as above) is 373 bp and overlaps the triplet repeat as well (Fig.
5C). However, unlike the FMR1 origin, the (CCG)n repeat is in the template for the lagging
strand, potentially resulting in the expansion of the complementary (GGC)n repeat in the
nascent strand that is synthesized discontinuously, consequent to the generation of unusual
secondary structures, such as stable hairpins. For this origin configuration, the risk of
amplification would be lessened if the repeat tract were replicated from another origin active
on its 3′ side (Fig. 5D). According to this model for the amplification of triplet repeats, it would
appear that the configuration at the FRAXE origin site is much more conducive to expansion
than the one at the FRAXA site. This conclusion, however, is not supported by the observed
prevalence of full mutation of 1 in 5530 for FRAXA and 1 in 23423 for FRAXE (Youings et
al., 2000). Therefore, it is likely that different molecular mechanisms are responsible for
expansion at the FRAXA and FRAXE sites, thus accounting for the differences in the incidence
of these mutations among fragile X syndrome patients.
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Nascent strand abundance analysis in the human FMR1 promoter region of NHF1-
hTERT cells. Each marker shown in this histogram was tested at least three times using nascent
DNA prepared from normal human fibroblasts (NHF1-hTERT cells). Error bars show the
standard deviation. A second preparation of nascent DNA from these cells was also tested (each
marker tested at least twice) with the same results. The width of each bar in the histogram is
proportional to the size of the PCR product and is plotted based on sequence data available at
genome.ucsc.edu. Below the histogram are indicated the percent GC in 5-base windows (dark
areas: high GC content, light areas: low GC content), the position of the transcriptional
promoter (Drouin et al., 1997) and FMR1 exon 1, the associated CpG island and trinucleotide
repeat (based on data also available at genome.ucsc.edu). The shaded box drawn around the
peak of abundance delimits the boundary of the “initiation region” as defined in the text.
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Nascent strand abundance analysis in the human FMR1 promoter region of GM1604-
hTERT cells. The relative abundance of markers in a preparation of short nascent DNA from
GM1604-hTERT, a fetal lung fibroblast cell line, was determined as described for NHF1-
hTERT cells. Each primer set was tested at least twice and error bars show the standard
deviation. These results indicate that the origin of replication associated with the FMR1
promoter is found in the same location in both the neonatal and fetal fibroblast cell lines that
were tested.
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Reverse Transcription PCR. RT-PCR of FMR1 and FMR2 messenger RNA in total RNA
isolated from log phase NHF1-hTERT (lane 1), 1604-hTERT (lane 2), and CRL-1502 (lane 3)
cells. Products were visualized on a 2% agarose gel stained with ethidium bromide (shown in
reverse contrast). A negative control (no template DNA) was also included (lane 4). Results
show that FMR1 is expressed in both cell types analyzed for replication origin activity while
FMR2 is expressed in neither. We also analyzed cDNA from CRL-1502 cells (female fetal
lung fibroblast cells) as a positive control. The resulting PCR product had the expected size,
indicating that the FMR2 primer set was working correctly.
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Determination of the timing of replication of the FMR1 gene in NHF1-hTERT cells. Newly
synthesized DNA from seven different 1-h S phase intervals was tested by quantitative PCR
to determine when the FMR1 gene region replicates. Panel A: Image of PCR products separated
on an ethidium bromide-stained agarose gel (shown in reverse contrast). S-phase fractions were
each tested in duplicate. Images were scanned and bands quantified as described in the
Materials and Methods section. Panel B: Bar graph illustrating the abundance of the marker
in each of the seven 1-h S-phase samples. Relative abundance was calculated from the linear
regression equation of the standard curve and expressed as a percentage of the highest value.
Results are the average of two tests and error bars indicate the standard deviation. A second
synchronization was tested with similar results. These data indicate that FMR1 replicates very
late in S phase, approximately at the same time as the FMR2 gene region (Chastain et al.,
2006).
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Schematic representation of the relative position of initiation region and triplet repeats
for the FMR1 and FMR2 origins. The boxed areas in A and C represent the “initiation region”
for the found origins spanning from the midpoint of the sequence between markers D and E to
the midpoint of the sequence between marker E and F (illustrated in Fig. 1). The position and
type of triplet repeats are indicated for FMR1 (A, B) and FMR2 (C, D) (Chastain et al.,
2006). The schematics in A and C illustrate the position of leading and lagging replicating
strands with respect to the active origin and the triplet repeats. The schematics in B and D
illustrate a hypothetical origin active on the 3′ site of the respective origin, and the consequent
possible formation of misprimed fragments during replication. The asterisk indicates the triplet
repeat configuration in the template that is more likely to cause mispriming in nascent
fragments.
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Table 1
Primer sets used for nascent strand abundance and replication timing analyses.
Primer Set Sequence Position in X
Chromosome
Product Size Annealing Temp.(°
C)
FMR1A-F# CTGAAAATTGAGGAGCAAAG 146697178-146697197 183 52
FMR1A-R# ACTACAAGCCACACTCAACC 146697342-146697361
FMR1B-F TGTCCACCTACTTTGCTAGG 146697879-146697898 152 52
FMR1B-R GCTGGTATCCAACTGAGAAG 146698012-146698031
FMR1C-F ATACAGTAGGGGCAGAAATG 146698212-146698231 181 52
FMR1C-R TAAGGGACATGGATTGAGTC 146698358-146698377
FMR1D-F GACTCAATCCATGTCCCTTA 146698358-146698377 173 52
FMR1D-R AGGGGTGAAGGATTAGACAG 146698512-146698531
FMR1E-F*& CCCAGGCCACTTGAAGAGAG 146698865-146698884 160 64
FMR1E-R ACCGGAAGTGAAACCGAAAC 146699006-146699025
FMR1F-F*& CTCCCTTTTCTTCTTGGTG 146699337-146699355 178 57
FMR1F-R GGTCTCTCATTTCGATAGGC 146699496-146699515
FMR1G-F TTATTCCCCCTTTCCTAAAC 146699642-146699661 330 52
FMR1G-R GCTAGACCGGAAAAGAGAAG 146699953-146699972
FMR1H-F GCGTCTAAAACCATTAGCAG 146700051-146700070 224 52
FMR1H-R AAAGCCTCAACAATTCAGTC 146700256-146700275
FMR1I-F TAGCAGTAGTGCGTTTGTTG 146700374-146700393 227 52
FMR1I-R AAAGCTGTCCTGTCTGAAAC 146700582-146700601
FMR1J-F& GTGTGTGTCAGACAAATTGC 146701286-146701305 246 52
FMR1J-R ACACTTCTCCACAGCAGTTC 146701513-146701532
#
Primer set used to determine the time of replication of the origin region.
*
Primer sets requiring 2-step PCR amplification conditions.
&
Primer sets requiring the addition of 2% DMSO in the amplification reaction.
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